AngioDynamics Inc. (ANGO)
undefined
undefined%
At close: undefined
9.27
0.00%
After-hours Jan 06, 2025, 04:00 PM EST

AngioDynamics Inc. Revenue Breakdown

Quarter Aug 31, 2024May 31, 2024Feb 29, 2024Nov 30, 2023Aug 31, 2023May 31, 2022Feb 28, 2022Nov 30, 2021Aug 31, 2021
Med Device Revenue 39.52M 41.64M 49.34M 53.71M 52.82M 64.40M 54.36M 59.39M 59.35M
Med Device Revenue Growth -5.10% -15.59% -8.14% +1.69% -17.98% +18.47% -8.48% +0.07% n/a
Med Tech Revenue 27.97M 29.34M 25.84M 25.36M 25.86M 22.60M 19.61M 18.89M 17.62M
Med Tech Revenue Growth -4.66% +13.51% +1.90% -1.92% +14.42% +15.24% +3.84% +7.19% n/a

Revenue by Geography

Quarter May 31, 2024May 31, 2023May 31, 2022May 31, 2021May 31, 2020May 31, 2019May 31, 2018May 31, 2017May 31, 2016May 31, 2015May 31, 2014
International Revenue 52.43M 84.33M 146.88M 121.43M 98.97M 106.77M 273.33M 282.17M 283.52M 280.85M 280.19M
International Revenue Growth -37.83% -42.58% +20.96% +22.70% -7.31% -60.94% -3.13% -0.48% +0.95% +0.24% n/a
United States Revenue 251.49M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Aug 31, 2024May 31, 2024Feb 29, 2024Nov 30, 2023Aug 31, 2023May 31, 2023Feb 28, 2023Nov 30, 2022Aug 31, 2022May 31, 2022Feb 28, 2022Nov 30, 2021Aug 31, 2021May 31, 2021Feb 28, 2021Nov 30, 2020Aug 31, 2020May 31, 2020Feb 29, 2020Nov 30, 2019Aug 31, 2019May 31, 2019Feb 28, 2019Nov 30, 2018Aug 31, 2018May 31, 2018Feb 28, 2018Nov 30, 2017Aug 31, 2017May 31, 2017Feb 28, 2017Nov 30, 2016Aug 31, 2016May 31, 2016Feb 29, 2016Nov 30, 2015Aug 31, 2015May 31, 2015Feb 28, 2015
Selling, General, and Administrative Revenue 36.58M 35.02M 35.98M 34.75M 38.22M 36.52M 34.24M 36.84M 36.64M 37.94M 29.14M 33.28M 33.39M 32.95M 28.62M 29.39M 26.26M 26.43M 31.14M 31.11M 27.83M 30.40M 28.19M 29.61M 27.93M 28.84M 25.73M 26.51M 27.46M 28.79M 26.47M 27.31M 27.66M 28.10M 27.09M 28.66M 27.99M 27.88M 26.27M
Selling, General, and Administrative Revenue Growth +4.45% -2.67% +3.54% -9.08% +4.66% +6.65% -7.05% +0.54% -3.41% +30.17% -12.44% -0.31% +1.33% +15.14% -2.64% +11.92% -0.63% -15.12% +0.10% +11.76% -8.46% +7.84% -4.77% +6.00% -3.17% +12.09% -2.92% -3.46% -4.63% +8.78% -3.07% -1.26% -1.57% +3.74% -5.49% +2.40% +0.39% +6.11% n/a
Research and Development Revenue 6.29M 6.72M 8.19M 8.66M 7.94M 7.86M 6.85M 6.84M 8.33M 7.87M 7.28M 8.20M 7.39M 9.10M 8.56M 9.71M 9.01M 7.23M 8.39M 7.76M 6.29M 7.20M 7.21M 7.36M 7.66M 6.45M 6.46M 6.11M 6.44M 6.70M 5.95M 5.91M 6.71M 6.94M 5.81M 6.18M 6.20M 7.29M 6.86M
Research and Development Revenue Growth -6.53% -17.89% -5.42% +9.03% +1.03% +14.71% +0.20% -17.94% +5.94% +8.05% -11.21% +10.89% -18.78% +6.29% -11.81% +7.80% +24.57% -13.85% +8.13% +23.39% -12.61% -0.14% -2.08% -3.90% +18.72% -0.05% +5.73% -5.19% -3.81% +12.52% +0.64% -11.86% -3.29% +19.44% -6.00% -0.37% -14.91% +6.33% n/a
Sales and Marketing Revenue 25.61M 24.58M 25.41M 25.46M 27.37M 26.29M 25.41M 26.01M 26.54M 26.83M 20.42M 23.61M 24.45M 23.82M 19.61M 20.17M 17.70M 18.21M 20.93M 20.11M 19.38M 21.84M 19.41M 20.27M 19.43M 20.90M 18.01M 18.97M 19.40M 20.48M 19.47M 19.52M 19.49M 21.19M 20.30M 20.57M 20.56M 20.22M 19.36M
Sales and Marketing Revenue Growth +4.17% -3.24% -0.23% -6.96% +4.09% +3.49% -2.31% -2.02% -1.08% +31.43% -13.51% -3.44% +2.63% +21.49% -2.81% +13.95% -2.76% -13.03% +4.08% +3.78% -11.28% +12.52% -4.22% +4.30% -7.01% +16.04% -5.05% -2.24% -5.25% +5.17% -0.28% +0.18% -8.04% +4.38% -1.30% +0.05% +1.69% +4.46% n/a